ECT2 and breast carcinoma: For example, miR-223-3p repressed the metastasis and progression of osteosarcoma cells by targeting CDH6 [20], over-expression of miR-223-3p suppressed the proliferation, invasion, and migration of breast cancer cells by targeting the ECT2 oncogene [21].